The lab's identifier and test date are published on the Certificate of Analysis for that batch
Toxicity evaluation According to a patent, "Short duration safety studies with Dihexa have uncovered no apparent toxicity
How to Source GHK-Cu 50 mg, BPC-157 Pen device with Cartridge Box (R&D Only) for Pharmaceutical Formulation GHK-Cu 50 mg, BPC-157 Pen device with Cartridge Box (R&D Only) (Prefilled syringe, 70 mg) is classified under R&D
The IA will be cognizant of instances where two DSRIP partners/providers do not overlap, but between the partners a Medicaid member is reported twice for the same project across multiple PPS
However, combination studies are limited and no established guidelines exist for combining these peptides
For higher servings, please consult your healthcare provider